• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Steroid Profiles
  • Steroid Articles
    • Contributors
  • Steroid Forum
MESO-Rx

MESO-Rx

Anabolic Steroids

  • Anabolic Steroids
    • Anadrol
    • Anavar
    • Deca Durabolin
    • Dianabol
    • Equipoise
    • Masteron
    • Oral Turinabol
    • Primobolan Depot
    • Sustanon 250
    • Testosterone
    • Trenbolone Acetate
    • Winstrol Depot
  • hGH & Peptides
    • CJC-1295
    • GHRP-6
    • hGH
    • hCG
    • IGF-1
    • Melanotan II
    • MGF
    • Mod GRF 1-29
    • TB-500
  • Anti-Estrogens
    • Arimidex
    • Aromasin
    • Clomid
    • Letrozole
    • Nolvadex
  • Fat Loss
    • AICAR
    • Albuterol
    • Clenbuterol
    • DNP
    • Ephedrine
    • T3
    • Telmisartan
You are here: Home / Steroid News / Use of Biosimilar EPO Agents Widespread at 2008 Tour de France

Use of Biosimilar EPO Agents Widespread at 2008 Tour de France

July 21, 2008 by Millard Leave a Comment

Epogen - Erythropoietin EPO

A BBC investigation suggests that most athletes who use recombinant human erythropoietin (EPO) continue to get away with it. The investigative article reveals several reasons why the EPO test is failing. But the BBC revealed that the biggest problem is not the ineffectiveness of the existing EPO tests used by the World Anti-Doping Agency (WADA). It is a lack of testing for variants of EPO.

Athletes are using various “biosimilar” EPO agents for which WADA has not yet developed a detection method. WADA’s ballyhooed test for the previously undetectable Mircera (pegylated EPO) was an admission that the already flawed existing EPO test was unable to detect variants of EPO; the announcement of the new CERA (Mircera) test at the 2008 Tour de France was considered a major victory.

There are also dozens of “copycat” or “biosimilar” versions of EPO. These are variants of EPO that are produced by different methods or exist as slightly different biological forms of EPO e.g. darbepoetin alfa, epoetin alfa, epoetin beta, epoetin gamma, epoetin delta, epoetin epsilon, epoetin zeta, epoetin theta, epoetin kappa, epoetin omega. The existence of biosimilar versions of EPO is a major problem for drug testers (“Concerns over Olympic drug test,” July 21).

Because the medicine has been so successful financially, companies in India, China and Cuba have developed drugs that do a similar job in the body, but have a slightly different molecular fingerprint. These cheap versions of EPO, often called biosimilars, can be easily bought over the internet.

[…]

“There are now a number of compounds that bind to the EPO receptor, and there is no single test for them, you can order it here over the internet and it will be delivered to you here in the UK or in Germany; Chinese-made doping substances” [according to Professor Werner Franke].

Some scientists who track and monitor the development of copycat EPO drugs say there could be up to 80 different versions now being manufactured in different parts of the world.

A few biosimilar versions are available in the EU and Eastern Europe; however, a plethora of doping options are commercially available with biosimilar EPO pharmaceuticals produced around the world, particularly in Southeast Asia, several of which could be purchased inexpensively over the internet.

Abseamed (Medice Arzneimittel Pütter)
Aranesp (Amgen)
Binocrit (Sandoz)
Bioetin (Nanogenpharma) [Vietnam]
Ceriton (Rambaxy) [India]
Dynepo (Shire)
Epocim (CIMEQ) [Cuba]
Epoetin Alfa Hexal (Hexal Biotech Forschungs)
Epofer (Emcure) [India]
Epofit (INTAS Pharmaceuticals) [India]
Epogin (Chugai Pharmaceutical Company) [Japan]
Epokine (Macropharma Corporation) [Philippines]
Eporon (Century Pharmaceuticals) [India]
Eporon (Dong-A Pharmaceutical Company) [Korea]
Eposino (Shandong Kexing) [China]
Eposino (Hindustan Bio Sciences) [India]
Epotin (Claris Lifesciences) [India]
Epotrex-NP (Novell Pharmaceutical) [Indonesia],
Epoyet (Bio Sudis) [Argentina],
Eritina (Chalver Laboratories) [Columbia]
Eritrogen (Bioprofarma) [Argentina]
Eritromax (Blausiegel ) [Brazil],
Erykine (INTAS Pharmaceuticals) [India]
Erypo (Janssen-Cilag)
Espo (Kirin Brewery Company, Pharmaceutical Division) [Japan]
Espogen (Hoffman Health) [Pakistan]
Gerepo (North China Pharmaceutical Group Corporation) [Malaysia]
Hemapo (Innogene Kalbiotech) [Singapore]
Hemax (Seignior Pharma) [Pakistan]
Hypercrit (Biogalenic) [Venezuela]
Mircera (Roche)
NeoRecormon (Roche)
PDpoetin (Pooyesh Darou Pharmaceuticals) [Iran]
Renoge (Biomedis) [Philippines]
Retacrit (Hospira/STADA) [Germany]
Shanpoietin (Shanta Biotechnics) [India]
Silapo (Bioceuticals Arzneimittel AG)
Vintor (Emcure) [India]
Wepox (Wockhardt) [India]
Zyrop (Zydus Biogenyc) [India]

I think the science director of WADA could be considered delusional in his claim that WADA is catching all users of recombinant EPO.

Dr Olivier Rabin is WADA’s science director. Is he happy that the test is catching all the drug cheats?

“I am reasonably confident, yes,” he told the BBC. “Now, it would be very presumptuous on my part to say that we are absolutely 100% sure we are going to get everyone. But I can assure you that if you were to take recombinant EPO and that would be in your urine – then, yes, we would detect it.“

Maybe the public will buy it, but the athletes already know better.

Hat tip to Trust But Verify.

Tour de France doping - anabolic steroids, erythropoietin (EPO) and testosterone
Tour de France doping – anabolic steroids, erythropoietin (EPO) and testosterone
Epogen - Erythropoietin EPO
Epogen – Erythropoietin EPO

About the author

Millard
Millard
MESO-Rx | Website

Millard writes about anabolic steroids and performance enhancing drugs and their use and impact in sport and society. He discusses the medical and non-medical uses of anabolic-androgenic steroids while advocating a harm reduction approach to steroid education.

Filed Under: Steroid News Tagged With: EPO, epogen, mircera

No replies yet

Start the discussion →

Loading new replies...

Join the full discussion at the MESO-Rx →

Primary Sidebar

Sponsors

Popular Articles

Two week protocol

How Has Your Two-Week Steroid Cycle Protocol Changed?

Question: Mr Roberts, I've been reading for the last several years to learn about anabolic steroids, because I definitely plan to use them someday. So far though I keep making gains without them and I want to … [Read More...] about How Has Your Two-Week Steroid Cycle Protocol Changed?

The Science of Trenbolone, Part 4

The Science of Trenbolone, Part 4

As we close out this article series, there are still some important aspects of trenbolone left to cover. So, in this final installment, we are going to start off discussing how androgens impact fat stores. We’ll … [Read More...] about The Science of Trenbolone, Part 4

Halotestin insights

Fluoxymesterone Insights: Unique Characteristics of Anabolic-Androgenic Steroids – Part 3

Introduction Fluoxymesterone (Halotestin®; Androxy®; “Halo”), a member of the androst-4-ene-3-one class of androgens, an11β-hydroxylated orally administered AAS that is 5α/β-reducible and relatively … [Read More...] about Fluoxymesterone Insights: Unique Characteristics of Anabolic-Androgenic Steroids – Part 3

Ask Bill Roberts

Ask Bill Roberts #8

DHT, the scalp, and Propecia Dear Mr. Roberts: Thanks for providing a remarkably honest voice on the topic of sports pharmacology. I know you've answered questions on steroid-related exacerbation of male … [Read More...] about Ask Bill Roberts #8

How Much Mass Gains Can Be Expected in a Steroid Cycle?

How Much Mass Gains Can Be Expected in a Steroid Cycle?

Q: “How much mass gains can be expected in a steroid cycle? Obviously later cycles won't yield as much as the first cycle, but overall how does it work?” A: In a first cycle, retained muscle gains can be as high … [Read More...] about How Much Mass Gains Can Be Expected in a Steroid Cycle?

Footer

MESO-Rx International

MESO-Rx articles are also available in the following languages:

Deutsch, English, Español, Français, Português, Русский

Questions? Comments?

Use the following link to send us an e-mail. We will respond as soon as we can.

Contact us.

Search

Copyright © 1997–2025 MESO-Rx. All rights reserved. Disclaimer.